February 2, 2015 -- Viropro Announces Results of Strategic Review and Plan for Restructuring
Viropro is an integrated developer and manufacturer of biopharmaceutical products that address unmet medical need in an efficient and cost-effective way.
Operating primarily through its wholly-owned subsidiary Alpha Biologics, the company has a team of experts and a state-of-the-start production facility that can rapidly move from benchtop to bedside.
We intend to develop our own products for commercial sale as well as make our facility available for contract manufacturing. With access to a highly trained work force and low operating costs, Viropro should be your choice as a development partner for life-saving biotherapeutics.
Alpha Biologics houses a bio-manufacturing facility located in Penang, Malaysia built to US FDA and European EMEA current Good Manufacturing Practices (cGMP) standards. Our 5,000m2 plant located in the Penang Science Park was designed for the manufacture of biologics (including biosimilars) for pre-clinical and Phase I, II and III clinical trials and early stage commercial operations. Within the plant is state-of-the-art custom-made manufacturing equipment, including a 500L bioreactor capacity and room for expansion to commercial scale.